Wakamoto Pharmaceutical Co., Ltd. logo

Wakamoto Pharmaceutical Co., Ltd. (4512)

Market Closed
12 Aug, 06:00
JPX JPX
¥
270. 00
+6
+2.2727%
¥
9.89B Market Cap
- P/E Ratio
7% Div Yield
58,600 Volume
- Eps
¥ 264
Previous Close
Add Transaction
Day Range
265 271
Year Range
240 380
Want to track 4512 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4512 closed today higher at ¥270, an increase of 2.2727% from yesterday's close, completing a monthly increase of 0.3717% or ¥1. Over the past 12 months, 4512 stock lost -5.9233%.
4512 is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

4512 Chart

Wakamoto Pharmaceutical Co., Ltd. (4512) FAQ

What is the stock price today?

The current price is ¥270.00.

On which exchange is it traded?

Wakamoto Pharmaceutical Co., Ltd. is listed on JPX.

What is its stock symbol?

The ticker symbol is 4512.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 7%.

What is its market cap?

As of today, the market cap is 9.89B.

Has Wakamoto Pharmaceutical Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Wakamoto Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Tomoyuki Hirai CEO
JPX Exchange
JP3991200001 ISIN
Japan Country
403 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Wakamoto Pharmaceutical Co.,Ltd., headquartered in Tokyo, Japan, has a distinguished presence in the pharmaceutical industry, primarily focusing on the manufacture and sale of ethical and non-prescription drugs within the Japanese market. Originally established in 1929 under the name Society for Nutrition and Raising Children Co., Ltd., the company underwent a name change to Wakamoto Pharmaceutical Co.,Ltd. in July 1943. Since its inception, Wakamoto Pharmaceutical has dedicated itself to developing pharmaceutical products aimed at improving the health and well-being of its customers.

Products and Services

  • Strong and Granule Wakamoto:

    This product line is designed to aid in digestion, intestinal regulation, and nutritional supplementation. As one of the company's flagship offerings, it targets gastrointestinal health through a blend of ingredients formulated to enhance the digestive process.

  • Wakamoto Intestinal Remedy drug:

    An innovative solution tailored for those seeking relief from intestinal discomfort, this drug is a testament to Wakamoto's commitment to addressing gastrointestinal issues with scientifically-backed formulations.

  • AVANTBISE oral tablets:

    These oral tablets are a dietary supplement aimed at restoring the balance of oral flora. In an era where oral health is increasingly recognized as crucial to overall well-being, AVANTBISE stands out as a preventive measure against imbalances in oral bacteria.

  • Medicated toothpaste:

    Complementing its oral health lineup, Wakamoto has developed a medicated toothpaste designed to effectively clean teeth while also addressing specific dental concerns. This product underscores the company’s holistic approach to health, extending beyond traditional pharmaceuticals.

Contact Information

Address: 2-2-2, Nihonbashi Honcho
Phone: 81 3 3297 0371